TIAA CREF Investment Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$152K Hold
2018
Q4
$141K Hold
2018
Q3
$180K Sell
2018
Q2
$265K Buy